Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients
Annals of Medicine, 08/27/09
Hauta–aho M et al. – Co–medication in warfarin–treated in–patients is common and should be carefully evaluated to decrease the bleeding risk associated with warfarin therapy.
Related Articles
Safety of Concomitant Tamoxifen and Warfarin
Annals of Pharmacotherapy, 10/21/09
Relevance Score: 90%
Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation
Cerebrovascular Diseases, 11/12/09
Relevance Score: 89%
Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients
Clinical Medicine & Research, 10/09/09
Relevance Score: 87%
Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
Annals of Pharmacotherapy, 10/13/09
Relevance Score: 85%
Uninterrupted Warfarin for Periprocedural Anticoagulation in Catheter Ablation of Typical Atrial Flutter: A Safe and Cost-Effective Strategy
Journal of Cardiovascular Electrophysiology, 10/06/09
Relevance Score: 85%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide
Clinical Therapeutics, 12/01/09
Sponsor
Article Search
Sponsor